In the perpetual pursuit of a more efficient clinical research process, biopharmaceutical sponsors and contract research organizations (CROs) have traditionally focused their resources on the more costly and time-consuming aspects of study start-up such as protocol development, regulatory and ethical…
Clinical Trials Are About Hope and Possibilities, Author and Trial Veteran Says
In 2011, Mary Elizabeth Williams was diagnosed with metastatic melanoma, a finding that usually means a patient has six to seven months to live. Knowing melanoma doesn’t respond well to traditional cancer treatments, she decided to take a chance on…
Intentional or Accidental, Bad Data Can Kill Trials and Careers
Two kinds of data integrity problems cast shade on research results and erode trust in scientific inquiry: questionable research practices and flat-out misconduct, a data integrity expert says. And while intentional misdeeds can result in regulatory, or even criminal, action,…
Avoid Enrollment Pitfalls: Find Your Best-fit Clinical Trial Sites
Selecting the right site is the single most crucial decision you’ll make about your next clinical trial. And perhaps the single most important consideration in selecting a site is whether it can make its enrollment. Many don’t; in fact, 20-25…
Removing Barriers: Reimbursement and Compensation for Participation in Oncology Clinical Trials
It is an often-repeated statistic that only 3% -5% of patients with cancer participate in clinical trials for cancer therapies. The reasons for this are myriad. One survey found that only 16% of patients were aware of relevant clinical trials…
Small Biopharmas Face Unique Challenges Outsourcing Early-Stage Drug Development Issues
By partnering with external drug development service providers, small biopharmaceutical start-ups can move their products out of the lab and into clinical development more efficiently. At the forefront of the biopharmaceutical revolution are hundreds of small start-up companies with…
Are remote clinical trials cheaper?
In 2014, The Tufts Center for the Study of Drug Development estimated the cost of bringing a drug to market to be $2.6 billion.1 With such escalating costs and drug pricing discussions at an all-time high, many companies are exploring…
“Hey Alexa, find a Clinical Trial for me….”
In this age of smart phones, cloud-based voice helpers and all things “Google” the public and medical profession have many ways to find a clinical trial. The most comprehensive listing of clinical trials in the world can be found at…
CRAs are at risk of work-related mental health disorders
Clinical research associate (CRA) turnover has long been a complex and challenging issue. We can recruit more CRAs, increase publicity in colleges, and introduce assessment standards. I could quote various statistics regarding turnover, but I won’t. This article is not…
CROs Deliver Shorter Cycle Times, Says New Tufts Report
Contract research services are now the largest single cost category in pharma R&D spending, accounting for almost $90 billion last year, according to Tufts Center for the Study of Drug Development. All in, CROs raked in about $33 billion last…